Table 1.
Medical condition | Number of patients | Countrya (n) |
Age (years ± SD) |
Gender (%) | INRb, c (n) | Patients with prior medicationd (n) | |||||
US | NL | FR | Male | Female | <2 | [2;3] | >3 | ||||
Atrial fibrillation | 426 | 152 | 251 | 23 | 68 ± 9.5 | 70 | 30 | 152 | 207 | 64 | 72 |
Deep venous thrombosis | 87 | 58 | 0 | 29 | 54.6 ± 16.8 | 48 | 52 | 77 | 0 | 0 | 0 |
Pulmonary embolism | 139 | 24 | 58 | 57 | 59.9 ± 16.4 | 52 | 48 | 11 | 1 | 0 | 0 |
a US, The United States; NL, The Netherlands; FR, France
b INR, International Normalized Ratio; MD
c MD, missing data = 39
d Patients who had already received antithrombotic agents prior to participation in the study